Vir Biotechnology, Inc. (VIR)
NASDAQ·Healthcare·Biotechnology
$13.72
+12.86%
Mkt Cap $1.91B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (21 analysts)
$23.50
Range $22.00 – $25.00
Implied Upside
+71.3%
Consensus $23.50 vs current $13.72
NASDAQ·Healthcare·Biotechnology
$13.72
+12.86%
Mkt Cap $1.91B
Buy
4
Hold
0
Sell
0
Price Target (21 analysts)
$23.50
Range $22.00 – $25.00
+71.3%
Consensus $23.50 vs current $13.72